Johnson & Johnson Claims Its Single-shot COVID-19 Vaccine Neutralizes Delta Variant


New Jersey, July 02: Johnson & Johnson announced findings from a small laboratory study, which revealed that the single-shot vaccine neutralizes the fast-spreading delta variant of COVID-19 and provides durable protection against infection.

It added that the vaccine jab generated strong, persistent activity against the Delta variant and other highly prevalent SARS-CoV-2 viral variants & study revealed that the durability of the immune response lasted for at least eight months.